Evrofarma SA (ATH:EVROF)
2.600
0.00 (0.00%)
Sep 30, 2025, 5:10 PM EET
Evrofarma Revenue
Evrofarma had revenue of 21.65M EUR in the half year ending June 30, 2024, with 9.90% growth. This brings the company's revenue in the last twelve months to 48.40M, up 3.32% year-over-year. In the year 2024, Evrofarma had annual revenue of 45.72M, down -6.24%.
Revenue (ttm)
48.40M
Revenue Growth
+3.32%
P/S Ratio
0.73
Revenue / Employee
291.55K
Employees
156
Market Cap
35.55M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.72M | -3.04M | -6.24% |
Dec 31, 2023 | 48.76M | 3.38M | 7.45% |
Dec 31, 2022 | 45.38M | 8.68M | 23.66% |
Dec 31, 2021 | 36.70M | 2.79M | 8.23% |
Dec 31, 2020 | 33.91M | 429.00K | 1.28% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Karelia Tobacco Company | 951.18M |
Gr. Sarantis | 601.70M |
Kri-Kri Milk Industry | 287.43M |
MIG Holdings | 9.10M |
Papoutsanis | 74.71M |
Loulis Food Ingredients | 206.78M |
Domain Costa Lazaridi | 24.82M |
Mediterra | 14.25M |